Products & Services
5-FU Therapeutic Implant
Adjuvant CGP 11637 Toxicity Studies Results Conducted
Adjuvant CGP 11637 Toxicity Studies Results Conducted in European FA
AL 721
Sites
Novartis Pharmanalytica SA
Audited
Country
City
Locarno
Address
Via Serafino Balestra 31, 6600
Novartis Ringaskiddy Ltd
Audited
Country
City
Cork
Novartis Pharma Schweizerhalle@Novartis Pharma Stein@Pharmaceutical Works Polpharma
Country
City
Starogard Gdański
Novartis Pharma AG
Audited
Country
City
Basel
Address
Kohlenstrasse 84, 4056
Novartis Pharma Stein AG
Audited
Country
City
Stein
Address
Schaffhauserstrasse 101, 4332